Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans

NCT06940895 is registered in ClinicalTrials.gov with Narrows Institute for Biomedical Research as lead sponsor.

NCT NCT06940895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06940895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans
Lead sponsor
Narrows Institute for Biomedical Research
Phase
Phase 2
Overall status
Completed
Start date
March 1, 2025
Completion date
July 18, 2025
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acanthosis nigricans